Featured Research

from universities, journals, and other organizations

Soy Substances Slow Prostate Cancer Growth In Animals

Date:
October 29, 1999
Source:
Ohio State University
Summary:
Substances present in dietary soy products may slow the growth of prostate cancer, a new animal study has shown. But cancer researchers warn against rushing to use them as diet supplements. The finding suggests that substances known as soy isoflavones are probably responsible for the anti-cancer effect.

COLUMBUS, Ohio -- Substances present in dietary soy products may slow the growth of prostate cancer, a new animal study has shown. But cancer researchers warn against rushing to use them as diet supplements.

The finding suggests that substances known as soy isoflavones are probably responsible for the anti-cancer effect.

“The study strongly supports the need for clinical trials to assess the potential role of soy in reducing the incidence and progression of human prostate cancer,” said Steven Clinton, associate professor of internal medicine at Ohio State University.

However, Clinton cautions against taking soy phytochemicals or dietary supplements enriched with soy isoflavones at this time.

“Soy phytochemicals are potent compounds. Plants use them to regulate genes during growth and development and as poisons to ward off predators,” said Clinton, who is also director of theCancer Prevention and Control Program at Ohio State’s Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. “Some of these chemicals may even enhance or promote the growth of some other types of tumors.

“Our results do suggest that including soy-based foods in the diet is reasonable for a number of health benefits. For example, consumption of soy protein has been shown to reduce blood cholesterol levels,” he said.

“The bottom line is that proper clinical studies need to be done to identify the benefits and potential side effects of these compounds.”

The study, which was led by Clinton and involved a team of researchers, was published in the September issue of the Journal of Nutrition.

It tested the ability of two types of soy extract, soy protein isolate and soy phytochemical concentrate, to inhibit the growth of human prostate cancer cells transplanted into mice.

Soy protein isolate is a high quality protein made from whole soy; it contains a very small amount of isoflavones. Soy phytochemical concentrate is an extract of soy that is rich in isoflavones (the amount is about 85 times greater than that found in soy protein isolate).

The study involved 48 mice divided into six groups. All the animals had been injected with a human prostate-cancer cells, which grow to form a tumor under the skin.

Three of the groups were fed soy protein isolate as their protein source. The remaining three groups, which formed the second arm of the study, received casein (milk protein) as their protein source.

One group in each arm was also fed an amount of soy phytochemical concentrate at a level equivalent to 0.2 percent of their diet; a second group in each arm was fed an amount equal to 1.0 percent of their diet.

After three weeks, the volumes of the tumors were compared in all the groups.

“We found that as the amount of isoflavones went up, the amount of tumor growth went down,” said Clinton.

For example, mice fed soy protein and no phytochemical concentrate had tumors that were 11 percent smaller than did the control mice that received casein only. Mice that received the highest level of isoflavones -- those fed soy protein plus 1 percent phytochemical concentrate -- had tumors that were 40 percent smaller than those in the casein-fed controls.

The researchers also attempted to learn how soy isoflavones retarded prostate tumor growth. They identified three possible mechanisms.

First, tumors receiving the highest levels of soy phytochemical concentrate had a lower rate of cell proliferation and higher numbers of cells undergoing programmed cell death, or apoptosis.

Second, there was a lower number of blood vessels in these tumors. This may reflect the ability of isoflavones to inhibit the growth of new blood vessels in the tumor (that is, they have antiangiogenic properties).

Third, animals fed isoflavones had lower levels of insulin-like growth factor 1, a hormone that stimulates the growth of prostate cancer.

This work was supported by grants from the National Institutes of Health and the Harvard Clinical Nutrition Research Center.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Soy Substances Slow Prostate Cancer Growth In Animals." ScienceDaily. ScienceDaily, 29 October 1999. <www.sciencedaily.com/releases/1999/10/991029071356.htm>.
Ohio State University. (1999, October 29). Soy Substances Slow Prostate Cancer Growth In Animals. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/1999/10/991029071356.htm
Ohio State University. "Soy Substances Slow Prostate Cancer Growth In Animals." ScienceDaily. www.sciencedaily.com/releases/1999/10/991029071356.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins